Amphastar Pharma (AMPH) Swings to Q3 Loss

Go back to Amphastar Pharma (AMPH) Swings to Q3 Loss

Form 8-K Amphastar Pharmaceutical For: Nov 12

November 12, 2014 4:13 PM EST

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event Reported): November 12, 2014

Amphastar Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in... More